Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan for heavy menstrual bleeding due to uterine fibroids (CTR20170438)
CTR20170438Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vilaprisan in Fibromyoma (LM), hypermenorrhea, sponsored by Bayer. Started Dec 2017; status: completed.
02
Drugs
vilaprisan
03
Conditions
Fibromyoma (LM)hypermenorrhea
Beyond the preview
Go deeper on CTR20170438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170438.